| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |